InvestorsHub Logo
Followers 140
Posts 29804
Boards Moderated 0
Alias Born 02/03/2005

Re: None

Wednesday, 10/03/2018 9:20:46 PM

Wednesday, October 03, 2018 9:20:46 PM

Post# of 372
Oct.3,2018..Repligen Corp. (NASDAQ: RGEN) was reiterated as Buy at Janney, which raised its fair value estimate to $70 from $56 (versus a $55.69 close) after news that the recent partnership with Sartorius Stedim opens a significant share of the global bioreactor market for the company.

Remember that when someone tries to convince you to buy or sell there is something in it for them. It's not because they are concerned about your investment.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RGEN News